Copyright
©The Author(s) 2020.
World J Gastrointest Surg. Aug 27, 2020; 12(8): 355-368
Published online Aug 27, 2020. doi: 10.4240/wjgs.v12.i8.355
Published online Aug 27, 2020. doi: 10.4240/wjgs.v12.i8.355
3nd month | 6th month | 9th month | ||||
Group A | Group C | Group A | Group C | Group A | Group C | |
CR | 11 (27.5) | 13 (32.5) | 11 (27.5) | 13 (32.5) | 11 (27.5) | 13 (32.5) |
PR | 14 (35.0) | 15 (37.5) | 14 (35.0) | 15 (37.5) | 14 (35.0) | 15 (37.5) |
SD | 13 (32.5) | 11 (27.5) | 12 (30.0) | 10 (25.0) | 10 (25.0) | 10 (25.0) |
PD | 2 (5.0) | 1 (2.5) | 3 (7.5) | 2 (5.0) | 4 (10.0) | 2 (5.0) |
Efficiency | 25 (62.5) | 28 (70.0) | 25 (62.5) | 28 (70.0) | 25 (62.5) | 28 (70.0) |
χ2 value | 0.701 | 0.583 | 0.855 | |||
P value | 0.873 | 0.900 | 0.836 |
- Citation: Zhang Y, Zhang MW, Fan XX, Mao DF, Ding QH, Zhuang LH, Lv SY. Drug-eluting beads transarterial chemoembolization sequentially combined with radiofrequency ablation in the treatment of untreated and recurrent hepatocellular carcinoma. World J Gastrointest Surg 2020; 12(8): 355-368
- URL: https://www.wjgnet.com/1948-9366/full/v12/i8/355.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v12.i8.355